Abbott Laboratories vs. IGC Pharma, Inc.
Abbott Laboratories and IGC Pharma, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | IGC | |
|---|---|---|
| Market Cap | $187.95 billion | $20.54 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | IGC | |
|---|---|---|
| Dividend Yield | 2.32% | — |
ABT and IGC split the dividend factors evenly.
Risk & Sentiment
| ABT | IGC | |
|---|---|---|
| Short Interest | 0.57% | 0.52% |
IGC leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, IGC overview, IGC financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
